Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Analysts at William Blair lifted their Q1 2025 earnings estimates for shares of Neumora Therapeutics in a research report issued to clients and investors on Monday, March 3rd. William Blair analyst M. Minter now anticipates that the company.
Publicado el: 2025-03-07 12:18:54
Autor: lulegacy, Fuente: lulegacy